Description:

S0502 Off Treatment Notice S0502 Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor NCT00324987 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FCCFD537-4859-4344-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FCCFD537-4859-4344-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 9/19/12
  2. 1/8/15
  3. 3/24/15
Uploaded on:

March 24, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Gastrointestinal Stromal Tumor NCT00324987

No Instruction available.

  1. StudyEvent: S0502 Off Treatment Notice
    1. No Instruction available.
Header
Off Treatment
Off Treatment Reason (select one:)
Was treatment termination medically required (For any adverse event,)
Was reason due to adverse event/side effects/complications (For any patient refusal,)
Will patient receive further treatment?
Vital Status

Similar models